| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Net (loss) income | 10 | 22 | 19 | 32 | 38 | -51 | -1 |
---|
Depreciation, Amortization and Accretion, Net | - | - | 17 | 26 | 22 | 25 | 26 |
---|
Impairment loss | - | - | - | - | - | 2 | - |
---|
Amortization of intangible assets | - | - | 1 | 1 | 1 | 1 | 1 |
---|
(Gain) loss on disposal of assets | 0 | -0 | -0 | 0 | -0 | -1 | 0 |
---|
Bad debt expense | - | - | 0 | - | - | 20 | 0 |
---|
Amortization of Debt Issuance Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Accretion of debt discount | 0 | - | 0 | 1 | 0 | 0 | 0 |
---|
Deferred income taxes | - | - | 5 | 6 | -3 | -11 | -4 |
---|
Stock-based compensation, net | 1 | 2 | 3 | 3 | 4 | 3 | 3 |
---|
Employee stock purchase plan compensation | - | - | 0 | 0 | 0 | 0 | 0 |
---|
Change in contingent consideration fair value | - | - | -2 | -3 | -1 | - | - |
---|
Gain on bargain purchase, net of cash acquired | - | - | - | - | 39 | - | - |
---|
Accounts receivable | 3 | 18 | -4 | 41 | 11 | -33 | 18 |
---|
Unbilled receivables | - | - | - | -3 | -5 | 2 | -2 |
---|
Inventory | 1 | -4 | 7 | 1 | -5 | -2 | 5 |
---|
Prepaid expenses and other assets | -0 | 3 | 2 | -2 | 5 | -1 | -7 |
---|
Deferred revenue | -6 | -2 | 4 | 5 | 1 | 6 | -9 |
---|
Accounts payable | 1 | 9 | -2 | -5 | -0 | 5 | 5 |
---|
Accrued expenses and other liabilities | -0 | 2 | 2 | 1 | 5 | -2 | -1 |
---|
Income taxes payable | 7 | -7 | - | 1 | -1 | - | - |
---|
Net cash provided by operating activities | - | - | 51 | 45 | 26 | 32 | 5 |
---|
Acquisition, net of cash acquired | - | - | 30 | - | - | - | 7 |
---|
Purchases of property, plant and equipment | 3 | 51 | 96 | 26 | 9 | 11 | 13 |
---|
Proceeds from disposal of assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
---|
Net cash used in investing activities | - | - | -126 | -25 | -9 | -11 | -18 |
---|
Proceeds from Notes Payable | - | - | - | 31 | 1 | - | - |
---|
Repayments of notes payable | 1 | 0 | 1 | 3 | 5 | 7 | 7 |
---|
Payments under financing lease obligation | - | - | - | - | - | 0 | 0 |
---|
Payment of deferred financing and debt issuance costs | - | - | 0 | 2 | 0 | - | - |
---|
Proceeds from Lines of Credit | 1 | - | 84 | 53 | 6 | - | 10 |
---|
Repayment of revolving credit facility | 65 | - | 40 | 95 | 9 | - | 10 |
---|
Payment of contingent consideration | - | - | 0 | 2 | 0 | 0 | - |
---|
Proceeds from equity issuance | 138 | 26 | 0 | 0 | 0 | 0 | 0 |
---|
Royalty stock issuance | - | - | - | - | - | - | 1 |
---|
Purchase of treasury stock | 0 | 0 | 2 | 0 | 1 | 0 | 1 |
---|
Net cash used in financing activities | - | - | 41 | -18 | -8 | -7 | -7 |
---|
Effect of exchange rate changes on cash and cash equivalents | - | - | - | - | - | - | - |
---|
Net increase in cash and cash equivalents | - | - | -34 | 1 | 9 | 14 | -20 |
---|